Composition with acne removal efficacy

A composition and anti-acne technology, which is applied in the direction of drug combination, skin care preparations, cosmetics, etc., can solve the problems of low efficiency and increased production costs, and achieve the effects of improving efficiency, avoiding inactivation, and promoting healing

Inactive Publication Date: 2015-12-30
GUILIN PAVAY GENE PHARMA
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The addition of rhEGF in skin care products is too high, but th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Composition: 0.01% of rhEGF freeze-dried powder, 40% of North American witch hazel extract, 35% of hydrolyzed soybean protein and 24.99% of viola extract.

Embodiment 2

[0030] Composition: 0.05% of rhEGF freeze-dried powder, 20% of North American hamamelis extract, 50% of hydrolyzed soybean protein and 29.95% of viola extract.

Embodiment 3

[0032] Composition: 0.03% of rhEGF freeze-dried powder, 30% of North American witch hazel extract, 40% of hydrolyzed soybean protein and 29.97% of viola extract.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides composition with acne removal efficacy and a skin-care product containing the composition. The composition comprises a rhEGF (recombinant human epidermal growth factor), a hamamelis virginiana extracting solution, hydrolyzed soy protein and a viola mandshurica extract. In the skin-care product, the weight content of the composition is 1%-2%. In the acne-removal skin-care product, the weight content of the rhEGF is only 1-10 mu g/ml and is far lower than the conventional adding amount; the rhEGF is compounded with the hamamelis virginiana extracting solution, the hydrolyzed soy protein and the viola mandshurica extract to have a synergistic effect, the composition can clear pores, balance grease secretion, completely repair skin and improve the barrier function of the skin, a wound is healed in shorter time, and the scar formation is reduced, and acne is thoroughly removed without leaving marks.

Description

technical field [0001] The invention belongs to the technical field of cosmetics, and in particular relates to a composition with the effect of removing acne. Background technique [0002] Epidermal growth factor (EGF) is a multifunctional cell growth-promoting factor. It has a wide range of cell growth-promoting activities, accelerates the growth rate of human skin cells, and promotes the growth and reproduction of new skin cells. It is a decisive factor affecting skin health. However, with the increase of age and the deterioration of the environment, the content of EGF in the human body gradually decreases, resulting in damage to skin health. Natural EGF widely exists in mammals, its content is low, extraction is difficult and costly, people usually use rhEGF instead of natural EGF. rhEGF can stimulate the proliferation of various cells derived from the ectodermal rhEGF layer and endoderm, such as cornea and epithelium. Its biological effects include: 1) Promote the acti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K8/97A61K8/64A61Q19/00A61P17/10
CPCA61K8/97A61K8/64A61K8/645A61Q19/00A61Q19/008
Inventor 韦忠明黄启斌莫冬海马冲唐申秀秦芳
Owner GUILIN PAVAY GENE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products